• About us
• Contact

Advertisement

Organisation › Details

Tenpoint Therapeutics (Group)

Tenpoint is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. We are addressing the ultimate cause of vision loss by replacing diseased cells with healthy ones to permanently restore vision. Tenpoint’s global team is united by our passion for science and our commitment to patients. *

 

	Start	2020-11-25 renamed
	Today	Tenpoint Therapeutics Ltd.
	Predecessor	Tenzing Therapeutics Ltd.
	Industry	tissue engineering / regenerative medicine
	Industry 2	ophthalmic
	Person	Anglade, Eddy (Tenpoint Therapeutics 202307 CEO)
	Person 2	Guyer, David R. (Eyebiotech 202202 CEO formerly Eyetech 200508 CEO)
	Region	Cambridge, Cambridgeshire
	Country	United Kingdom (GB)
	Street	30 Broad Street Cambourne
	City	CB23 6HJ Cambridge, Cambridgeshire
		Address record changed: 2023-08-01
Basic data	Employees	n. a.
		* Document for »About Section«: Tenpoint Therapeutics Ltd.. (7/12/23). "Press Release: Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-based Therapeutics and In Vivo Reprogramming". London.
		Record changed: 2023-07-26

Advertisement

More documents for Tenpoint Therapeutics (Group)

• [1] Tenpoint Therapeutics Ltd.. (7/12/23). "Press Release: Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-based Therapeutics and In Vivo Reprogramming". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.